You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Form factor determination for the Talon microIPG system to treat Chronic Migraine

    SBC: NeoGenesis Technologies LLC            Topic: NINDS

    Project Summary Worldwidetens of millions are afflicted with chronic migraineCMa highly debilitating neurological disorderWhile abortive and preventative therapies existthere are still nearlymillion peopleM in the US alonewho do not respond adequately to these therapies and suffer from Intractable Chronic MigraineICMThose patients are highly disabled by their disease and are faced with a significa ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. An Automated Device for High Yield Mesenchymal Stem Cell Extraction

    SBC: CG SCIENTIFIC INC            Topic: NIBIB

    Project Summary Abstract This Phase II project aims to develop an automated system for extracting mesenchymal stem cellsMSCsalso known as multipotent stromal cellsfrom adipose tissues for treating many serious diseasesincluding myocardial infarctiongraft versus host diseaseand a variety of autoimmune diseasesOverclinical trials to date have established the feasibilitysafetyand in some cases effica ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  3. Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products (Phase II)

    SBC: LIBREDE            Topic: R

    AbstractCannabinoids are a class of natural products shown to treat a wide range of diseasesincluding epilepsyone of the most common neurological disordersEpilepsy affects people of all ageswith overmillion epileptics worldwide and overnew cases of epilepsy each year in the United States aloneEven with numerous anti epileptic drugsAEDavailableof patients have uncontrollable seizures that do not re ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Prehospital and Emergency Room Stroke Diagnosis Using Quantitative Cerebral Hemodynamics

    SBC: Neural Analytics, Inc.            Topic: NINDS

    Large vessel acute ischemic strokeAISis the leading cause of disability and fourth leading cause of death with approximatelyper year in the United States aloneAlthough treatments including interventionalstentrieverand pharmaceuticaltPAexist for large vessel occlusionLVOthere is not a rapid prehospital tool for diagnoses which guides the use of the correct therapyBecause the time to treatment for s ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information

    SBC: ARIMA GENOMICS, INC.            Topic: 172

    Commercialization of HaploSeq as a ServiceHaaSfor generating chromosome span phased genome and exome sequence information Arima Genomics SPECIFIC AIMSProject Summary Abstract Overof Next Generation SequencingNGSis sequenced via Illumina short read sequencersThis is because of its cost effectiveness and faster turn around timesHowevershort read sequencing technologies lose critical contiguity infor ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Pan-HIV Incidence Assay Development

    SBC: ImmPORT Therapeutics Inc dba Antigen Discovery Inc            Topic: NIAID

    PanHIV Incidence Assay DevelopmentAbstractHIVcontinues to cause the largest number of yearly deaths from a single infectious agent in the world todayDespiteconsiderableadvancesintreatmentofHIVinfectionandAIDSwhichitcausesthereisanurgentneed for better methods of prevention and treatment of HIVinfection and AIDSAs part of this effortthe WorldHealth OrganizationWHOand the Joint United Nations Progra ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. HeartMapp: A Closed-Loop Assessment and Treatment Mobile Application for Heart Failure

    SBC: POSIT SCIENCE CORP            Topic: 600

    PROJECT SUMMARY The goal of the current Phase I project is to developto clinical trial readinessand evaluate the feasibility and initial efficacy of a mobile applicationHeartMappdesigned to monitor and treat physical and cognitive symptoms related to heart failureHFin older adultsHeart failureHFis a leading cause of death in the US with costs estimated at $billion per annumfueled by the high rates ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay

    SBC: ImmPORT Therapeutics Inc dba Antigen Discovery Inc            Topic: NIAID

    DiscoveryofYellowFever VirusSpecificEpitopesforDevelopmentofanAccurateSerodiagnostic AssayAbstractAntibodies to many pathogenic viruses can be detected in bloodserum and or salivaAmong theseare many arbovirusesthat share endemic regions in the western hemisphere and in other parts of theworldThese include the related flaviviruses yellow fever virusYFVdengue virusDENVZika virusZIKVand West Nile vir ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Evaluating the impact of novel inhibitors of nuclear pore export in SLE

    SBC: KARYOPHARM THERAPEUTICS INC.            Topic: NIAID

    Systemic lupus erythematosusSLEis a complex autoimmune disease with a broad spectrum of clinical manifestations that affect several organsSLE affects millions of individualswith women and minorities disproportionately burdenedand is associated with significant morbidity and mortalityDespite considerable progress made towards understanding the disease and the identification of the central roles pla ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries

    SBC: ARC Bio, LLC            Topic: NIAID

    ABSTRACT Next generation sequencingNGShas the potential to revolutionize how infectious disease is diagnosed and treatedenabling the detection of a wide variety of pathogens in a single testHoweverdespite the increasing adoption of molecular diagnostics in clinical microbiology labsNGS has not become widespread due to its costturnaround timeand the technical and computational expertise required to ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government